Holen Sie sich die Stockscreener-App
42.34
0.38%
0.16
Schlusskurs vom Vortag:
$42.18
Offen:
$42.36
24-Stunden-Volumen:
294.83K
Relative Volume:
0.46
Marktkapitalisierung:
$1.78B
Einnahmen:
$17.39M
Nettoeinkommen (Verlust:
$-135.89M
KGV:
-9.125
EPS:
-4.64
Netto-Cashflow:
$-123.00M
1W Leistung:
+4.34%
1M Leistung:
+4.16%
6M Leistung:
-11.99%
1J Leistung:
+56.01%
1-Tages-Spanne:
$41.50
$42.74
1-Wochen-Bereich:
$40.51
$45.48
52-Wochen-Spanne:
$20.08
$57.28
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Firmenname
Tarsus Pharmaceuticals Inc
Sektor
Branche
Telefon
(949) 409-9820
Adresse
15440 LAGUNA CANYON ROAD, IRVINE
Vergleichen Sie TARS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
42.34 | 1.70B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-11-20 | Eingeleitet | Goldman | Neutral |
| 2023-07-18 | Eingeleitet | William Blair | Outperform |
| 2023-05-18 | Eingeleitet | Guggenheim | Buy |
| 2022-08-01 | Eingeleitet | Barclays | Overweight |
| 2021-12-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-23 | Eingeleitet | Oppenheimer | Outperform |
| 2020-11-10 | Eingeleitet | BofA Securities | Buy |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-11-10 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten
Arizona State Retirement System Purchases 470 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
What drives Tarsus Pharmaceuticals Inc. stock priceBreakthrough wealth creation - Autocar Professional
Is Tarsus Pharmaceuticals Inc. a good long term investmentOutstanding trading profits - jammulinksnews.com
What makes Tarsus Pharmaceuticals Inc. stock price move sharplyFree Stock Movement Tracking - Newser
What analysts say about Tarsus Pharmaceuticals Inc. stockTremendous gains - jammulinksnews.com
Tarsus Pharmaceuticals Inc. Stock Analysis and ForecastFree Trading Psychology Coaching - jammulinksnews.com
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Tarsus Pharmaceuticals (TARS) and Abbott Laboratories (ABT) - The Globe and Mail
Tarsus Pharmaceuticals Shares Soar 4.47% on Strong Sales, Earnings - AInvest
Tarsus Pharmaceuticals: A Compelling Case for Investment in the Era of Anterior Segment Innovation - AInvest
Tarsus Pharmaceuticals: Making Big Strides (NASDAQ:TARS) - Seeking Alpha
William Blair Has Bearish Estimate for TARS Q2 Earnings - Defense World
What is William Blair’s Forecast for TARS FY2026 Earnings? - Defense World
How Tarsus Pharmaceuticals Inc. stock performs during market volatilityFree Investment Risk Control - Newser
Why Tarsus Pharmaceuticals Inc. stock attracts strong analyst attentionHigh Return Potential - Newser
Bank of America Securities Reaffirms Buy Rating for Tarsus Pharmaceuticals at $68.00 - AInvest
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Acquired by Amalgamated Bank - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Analysts - Defense World
(TARS) Investment Analysis - news.stocktradersdaily.com
Janney Montgomery Scott LLC Sells 2,795 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals, Inc.(NasdaqGS:TARS) dropped from Russell Microcap Growth Index - MarketScreener
Tarsus Pharmaceuticals (NASDAQ:TARS) versus Protalix BioTherapeutics (NYSE:PLX) Financial Comparison - Defense World
Tarsus Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Tarsus Pharmaceuticals Becomes Oversold (TARS) - Nasdaq
When (TARS) Moves Investors should Listen - news.stocktradersdaily.com
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World
Rhumbline Advisers Increases Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth - Investing.com Australia
Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth By Investing.com - Investing.com India
Insider Sell: Aziz Mottiwala Sells 17,500 Shares of Tarsus Pharm - GuruFocus
Tarsus Pharmaceuticals CCO sells $765,800 in stock - Investing.com Australia
Tarsus Pharmaceuticals CCO sells $765,800 in stock By Investing.com - Investing.com Canada
Certain Common stock of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 11-JUN-2025. - marketscreener.com
Certain Stock Options of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 11-JUN-2025. - MarketScreener
Tarsus Pharmaceuticals at Goldman Sachs Conference: Strategic Growth Focus By Investing.com - Investing.com Canada
Transcript : Tarsus Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01 - MarketScreener
Stocks Showing Improving Market Leadership: Tarsus Pharmaceuticals Earns 87 RS Rating - MSN
Squarepoint Ops LLC Sells 51,329 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Finanzdaten der Tarsus Pharmaceuticals Inc-Aktie (TARS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):